Thus, the difference in cathepsin B activity we observed in the cases of AD-DS compared with EOAD is likely to be caused by a specific effect of three copies of Hsa21 on enzyme function and not the result of differences in tau pathology in the cases. Here, CTSB is linked to Dravet syndrome.